Distinguished in Venous Thromboembolism (VTE)

Anthony M. Maraveyas

Castle Hill, 
Castle, ENG, GB 
Distinguished in Venous Thromboembolism (VTE)
Castle Hill, 
Castle, ENG, GB 
OverviewLocationsClinical Research

Overview

Anthony Maraveyas practices in Castle, United Kingdom. Mr. Maraveyas is rated as a Distinguished expert by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis, and Mesenteric Venous Thrombosis.

His clinical research consists of co-authoring 119 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 39 articles in the study of Venous Thromboembolism (VTE).

Gender
Male

Locations

Castle Hill, Castle, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Randomised, Multicentre Open-label Study of Active Symptom Control (ASC) Alone or ASC With Oxaliplatin/ 5F-U Chemotherapy for Patients With Locally Advanced/ Metastatic Biliary Tract Cancers Previously Treated With Cisplatin/ Gemcitabine Chemotherapy.
A Phase III, Randomised, Multicentre Open-label Study of Active Symptom Control (ASC) Alone or ASC With Oxaliplatin/ 5F-U Chemotherapy for Patients With Locally Advanced/ Metastatic Biliary Tract Cancers Previously Treated With Cisplatin/ Gemcitabine Chemotherapy.
Enrollment Status: Completed
Publish Date: January 28, 2020
Intervention Type: Other, Drug
Study Phase: Phase 3

118 Total Publications

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
Journal: The New England journal of medicine
Published: March 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Maraveyas's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile